Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 1 , Pages 17-22 , January 2010

Hypoalbuminemia Predicts Acute Stroke Mortality: Paul Coverdell Georgia Stroke Registry

  • Bolanle Famakin, MD

      Affiliations

    • Department of Neurology, Emory University School of Medicine, Atlanta
    • ,
  • Paul Weiss, MS

      Affiliations

    • Department of Biostatistics, Emory University Rollins School of Public Health, Atlanta
    • ,
  • Vicki Hertzberg, PhD

      Affiliations

    • Department of Biostatistics, Emory University Rollins School of Public Health, Atlanta
    • ,
  • William McClellan, MD, PhD

      Affiliations

    • Department of Medicine, Emory University School of Medicine, Atlanta
    • ,
  • Rodney Presley, PhD

      Affiliations

    • Georgia Medical Foundation, Atlanta
    • ,
  • Kerrie Krompf, BS

      Affiliations

    • Department of Neurology, Emory University School of Medicine, Atlanta
    • ,
  • Herbert Karp, MD

      Affiliations

    • Department of Medicine, Emory University School of Medicine, Atlanta
    • ,
  • Michael R. Frankel, MD

      Affiliations

    • Department of Neurology, Emory University School of Medicine, Atlanta
    • Corresponding Author InformationAddress correspondence to Michael R. Frankel, MD, Department of Neurology, Box 036 Grady Hospital, 80 Jesse Hill Jr Dr SE, Atlanta, GA 30303.

Received 29 August 2008 ,Revised 22 January 2009 ,Accepted 30 January 2009.

References 

  1. American Heart Association. Heart disease and stroke statistics–2006 update. American Heart Association, 2006. Circulation. 2006;113:e85–151
  2. Anonymous . State-specific mortality from stroke and distribution of place of death–United States, 1999. MMWR Morb Mortal Wkly Rep. 2002;51:429–433
  3. Liebeskind DS, Sayre JW. Decreasing incidence of stroke in the United States: 1996-2000. Stroke. 2003;34:287;(abstr)
  4. Gillum LA, Johnston SC. Characteristics of academic medical centers and ischemic stroke outcomes. Stroke. 2001;32:2137–2142
  5. Bornstein NM, Aronovich BD, Karepov VG, et al. The Tel Aviv stroke registry: 3600 consecutive patients. Stroke. 1996;27:1770–1773
  6. Bonita R, Ford MA, Stewart AW. Predicting survival after stroke: A three-year follow-up. Stroke. 1988;19:669–673
  7. Chambers BR, Norris JW, Shurvell BL, et al. Prognosis of acute stroke. Neurology. 1987;37:221–225
  8. Cucchiara BL, Kasner SE, Wolk DA, et al. Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit Care Med. 2004;32:241–245
  9. Frankel MR, Morgenstern LB, Kwiatkowski T, et al. Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-pa stroke trial. Neurology. 2000;55:952–959
  10. Hamidon BB, Raymond AA. The impact of diabetes mellitus on in-hospital stroke mortality. J Postgrad Med. 2003;49:307–310
  11. Woo E, Chan YW, Yu YL, et al. Admission glucose level in relation to mortality and morbidity outcome in 252 stroke patients. Stroke. 1988;19:185–191
  12. Di Bonito P, Di Fraia L, Di Gennaro L, et al. Impact of known and unknown diabetes on in-hospital mortality from ischemic stroke. Nutr Metab Cardiovasc Dis. 2003;13:148–153
  13. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2001;32:2426–2432
  14. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al. German Stroke Registers Study Group Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: The German stroke registers study group. Arch Intern Med. 2004;164:1761–1768
  15. Arboix A, Garcia-Eroles L, Massons J, et al. Acute stroke in very old people: Clinical features and predictors of in-hospital mortality. J Am Geriatr Soc. 2000;48:36–41
  16. Baptista MV, van Melle G, Bogousslavsky J. Prediction of in-hospital mortality after first-ever stroke: The Lausanne stroke registry. J Neurol Sci. 1999;166:107–114
  17. Rordorf G, Koroshetz W, Efird JT, et al. Predictors of mortality in stroke patients admitted to an intensive care unit. Crit Care Med. 2000;28:1301–1305
  18. Korn E, Graubard B. Analysis of health surveys. New York: Wiley Press; 1999;
  19. Wattigney WA, Croft JB, Mensah GA, et al, Paul Coverdell National Acute Stroke Registry. Establishing data elements for the Paul Coverdell National Acute Stroke Registry, part 1: Proceedings of an expert panel. Stroke 2003;34:151–156.
  20. Borhani NO. Changes and geographic distribution of mortality from cerebrovascular disease. Am J Public Health. 1965;55:673–681
  21. Zuliani G, Cherubini A, Ranzini M, et al. Risk factors for short-term mortality in older subjects with acute ischemic stroke. Gerontology. 2006;52:231–236
  22. Gariballa SE, Parker SG, Taub N, et al. Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr. 1998;68:275–281
  23. Carter AM, Catto AJ, Mansfield MW, et al. Predictive variables for mortality after acute ischemic stroke. Stroke. 2007;38:1873–1880
  24. Ebersole JL, Cappelli D. Acute phase reactants in infections and inflammatory diseases. Periodontology. 2000;23:19–49
  25. Ramadori G, Van Damme J, Rieder H, et al. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse: Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol. 1988;18:1259–1264
  26. Clark WM, Beamer NB, Wynn M, et al. The initial acute phase response predicts long-term stroke recovery. J Stroke Cerebrovasc Dis. 1998;7:128–131
  27. Beamer NB, Coull BM, Clark WM, et al. Interleukin-6 and Interleukin-1 receptor antagonist in acute stroke. Annals of Neurology. 1995;37:800–805
  28. Intiso D, Zarelli MM, Lagioia G, et al. TNF alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci. 2004;24:390–396
  29. Gervois P, Kleemann R, Pilon A, et al. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. J Biol Chem. 2004;279:16154–16160
  30. Wayner DD, Burton GW, Ingold KU, et al. Quantitative measurement of the total, peroxyl radical trapping anti-oxidant capability of human blood plasma by controlled peroxidation; the important contribution made by plasma proteins. FEBS Lett. 1985;187:33–37
  31. Halliwell B, Gutteridge JM. The anti-oxidants of human extracellular fluid. Arch Biochem Biophys. 1990;280:1–8
  32. He P, Curry FE. Albumin modulation of capillary permeability; role of the endothelial cell (Ca2+)i. Am J Heart Circ Physiol. 1993;265:H74–H82
  33. Ginsberg MD, Palesch YY, Hill MD. The ALIAS (ALbumin in Acute Stroke) phase III randomized multicenter clinical trial: Design and progress report. Biochem Soc Trans. 2006;34:1323–1326
  34. MacWalter RS, Wong SY, Wong KY, et al. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study. Stroke. 2002;33:1630–1635
  35. Prass K, Braun JS, Dirnagl U, et al. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37:2607–2612
  36. Dirnagl U, Klehmet J, Braun JS, et al. Stroke-induced immunodepression: Experimental evidence and clinical relevance. Stroke. 2007;38:770–773(suppl)
  37. Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: Prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke. 2003;34:2617–2622
  38. Desmond DW, Moroney JT, Sano M, et al. Mortality in patients with dementia after ischemic stroke. Neurology. 2002;59:537–543
  39. Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78:188–191
  40. Rincon F, Mayer SA. Novel therapies for intracerebral hemorrhage. Curr Opin Crit Care. 2004;10:94–100
  41. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51–63

 The Paul Coverdell Georgia Stroke Registry Pilot Prototype is supported by Centers for Disease Control and Prevention Cooperative Agreement No. U50/CCU420275-01. Principal Investigator: Michael R. Frankel.

PII: S1052-3057(09)00038-X

doi: 10.1016/j.jstrokecerebrovasdis.2009.01.015

Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 1 , Pages 17-22 , January 2010

Article Tools

* Image Usage & Resolution